|
SFRS3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.215600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.489800E-02 |
| Normal-vs-Stage2 |
2.841800E-02 |
| Normal-vs-Stage3 |
4.42649999999878E-05 |
| Normal-vs-Stage4 |
5.53540000000075E-05 |
| Stage1-vs-Stage2 |
3.351200E-01 |
| Stage1-vs-Stage3 |
1.424960E-03 |
| Stage1-vs-Stage4 |
2.395400E-03 |
| Stage2-vs-Stage3 |
2.127600E-01 |
| Stage2-vs-Stage4 |
1.731380E-01 |
| Stage3-vs-Stage4 |
8.619200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.755400E-04 |
| Normal-vs-AfricanAmerican |
3.671800E-02 |
| Normal-vs-Asian |
6.376200E-01 |
| Caucasian-vs-AfricanAmerican |
6.914000E-01 |
| Caucasian-vs-Asian |
6.162000E-02 |
| AfricanAmerican-vs-Asian |
1.481790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.23230000000663E-05 |
| Normal-vs-Female |
5.913600E-02 |
| Male-vs-Female |
2.980300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.952200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.761000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.194900E-04 |
| Normal-vs-Age(81-100Yrs) |
8.814000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.080000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.993200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.035600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.183000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.768800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.042800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.236200E-01 |
| Normal-vs-Grade 2 |
2.112600E-01 |
| Normal-vs-Grade 3 |
3.6075999999996E-05 |
| Normal-vs-Grade 4 |
3.00760000015998E-07 |
| Grade 1-vs-Grade 2 |
4.401800E-02 |
| Grade 1-vs-Grade 3 |
4.26060000000561E-05 |
| Grade 1-vs-Grade 4 |
1.82631999999794E-05 |
| Grade 2-vs-Grade 3 |
4.58829999994137E-07 |
| Grade 2-vs-Grade 4 |
4.05740000486432E-08 |
| Grade 3-vs-Grade 4 |
2.514100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.224400E-01 |
| Normal-vs-ccB subtype |
3.47490000107697E-08 |
| ccA subtype-vs-ccB subtype |
7.56728013584507E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.415180E-03 |
| Normal-vs-N1 |
3.904700E-03 |
| N0-vs-N1 |
9.256300E-02 |
|
|
